742 related articles for article (PubMed ID: 10751361)
1. Openings between defective endothelial cells explain tumor vessel leakiness.
Hashizume H; Baluk P; Morikawa S; McLean JW; Thurston G; Roberge S; Jain RK; McDonald DM
Am J Pathol; 2000 Apr; 156(4):1363-80. PubMed ID: 10751361
[TBL] [Abstract][Full Text] [Related]
2. Endothelial gaps as sites for plasma leakage in inflammation.
McDonald DM; Thurston G; Baluk P
Microcirculation; 1999 Mar; 6(1):7-22. PubMed ID: 10100186
[TBL] [Abstract][Full Text] [Related]
3. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels.
Kohn S; Nagy JA; Dvorak HF; Dvorak AM
Lab Invest; 1992 Nov; 67(5):596-607. PubMed ID: 1279271
[TBL] [Abstract][Full Text] [Related]
4. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.
Feng D; Nagy JA; Dvorak AM; Dvorak HF
Microvasc Res; 2000 Jan; 59(1):24-37. PubMed ID: 10625568
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.
Inai T; Mancuso M; Hashizume H; Baffert F; Haskell A; Baluk P; Hu-Lowe DD; Shalinsky DR; Thurston G; Yancopoulos GD; McDonald DM
Am J Pathol; 2004 Jul; 165(1):35-52. PubMed ID: 15215160
[TBL] [Abstract][Full Text] [Related]
6. Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers.
di Tomaso E; Capen D; Haskell A; Hart J; Logie JJ; Jain RK; McDonald DM; Jones R; Munn LL
Cancer Res; 2005 Jul; 65(13):5740-9. PubMed ID: 15994949
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors.
Baluk P; Morikawa S; Haskell A; Mancuso M; McDonald DM
Am J Pathol; 2003 Nov; 163(5):1801-15. PubMed ID: 14578181
[TBL] [Abstract][Full Text] [Related]
8. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions.
Fukumura D; Yuan F; Endo M; Jain RK
Am J Pathol; 1997 Feb; 150(2):713-25. PubMed ID: 9033284
[TBL] [Abstract][Full Text] [Related]
9. Significance of blood vessel leakiness in cancer.
McDonald DM; Baluk P
Cancer Res; 2002 Sep; 62(18):5381-5. PubMed ID: 12235011
[TBL] [Abstract][Full Text] [Related]
10. Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumors.
Fenton BM; Paoni SF; Ding I
Radiother Oncol; 2004 Aug; 72(2):221-30. PubMed ID: 15297140
[TBL] [Abstract][Full Text] [Related]
11. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston G; McLean JW; Rizen M; Baluk P; Haskell A; Murphy TJ; Hanahan D; McDonald DM
J Clin Invest; 1998 Apr; 101(7):1401-13. PubMed ID: 9525983
[TBL] [Abstract][Full Text] [Related]
12. Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.
Magnussen A; Kasman IM; Norberg S; Baluk P; Murray R; McDonald DM
Cancer Res; 2005 Apr; 65(7):2712-21. PubMed ID: 15805270
[TBL] [Abstract][Full Text] [Related]
13. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows.
Yuan F; Salehi HA; Boucher Y; Vasthare US; Tuma RF; Jain RK
Cancer Res; 1994 Sep; 54(17):4564-8. PubMed ID: 8062241
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.
Morikawa S; Baluk P; Kaidoh T; Haskell A; Jain RK; McDonald DM
Am J Pathol; 2002 Mar; 160(3):985-1000. PubMed ID: 11891196
[TBL] [Abstract][Full Text] [Related]
15. Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model.
Hunter F; Xie J; Trimble C; Bur M; Li KC
Mol Cancer; 2006 Feb; 5():5. PubMed ID: 16457726
[TBL] [Abstract][Full Text] [Related]
16. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.
Brantley-Sieders DM; Fang WB; Hicks DJ; Zhuang G; Shyr Y; Chen J
FASEB J; 2005 Nov; 19(13):1884-6. PubMed ID: 16166198
[TBL] [Abstract][Full Text] [Related]
17. Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors.
Parsons-Wingerter P; Kasman IM; Norberg S; Magnussen A; Zanivan S; Rissone A; Baluk P; Favre CJ; Jeffry U; Murray R; McDonald DM
Am J Pathol; 2005 Jul; 167(1):193-211. PubMed ID: 15972964
[TBL] [Abstract][Full Text] [Related]
18. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
Nagy JA; Morgan ES; Herzberg KT; Manseau EJ; Dvorak AM; Dvorak HF
Cancer Res; 1995 Jan; 55(2):376-85. PubMed ID: 7529135
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion.
Kumar P; Ning Y; Polverini PJ
Lab Invest; 2008 Jul; 88(7):740-9. PubMed ID: 18490895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
